Zeynep Eroglu

11.3k citations
122 papers · 8.4k · 4 hit papers · h-index 37

Impact in

  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • Polyomavirus and related diseases
    • Ocular Oncology and Treatments

Papers in

    • Cancer Immunotherapy and Biomarkers 54
    • Cutaneous Melanoma Detection and Management 22
    • Polyomavirus and related diseases 8
    • Melanoma and MAPK Pathways 25
    • Hedgehog Signaling Pathway Studies 6

Zeynep Eroglu

114 papers receiving 8.2k citations

Zeynep Eroglu's Hit Papers

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial 2021 · 215 citations
2150+3+6Years since publication5001k1.5k2k

Peers

Zeynep Eroglu
Comparison fields: 5 of 97
  • Oncology 5.6k
  • Ophthalmology 341
  • Molecular Biology 1.2k
  • Cancer Research 239
  • Immunology 332
Replace Simone M. Goldinger with:
Simone M. Goldinger Switzerland
Roxana Stefania Dronca United States
April K.S. Salama United States
Oliver Edgar Bechter Belgium
Kenneth F. Grossmann United States
Naoya Yamazaki Japan
Ragini Reiney Kudchadkar United States
Kari Lynn Kendra United States
Marcus Otho Butler Canada
Henrik Schmidt Denmark
Zeynep Eroglu relative to Simone M. Goldinger Switzerland Simone M. Goldinger's profile →
Citations per field
00.5×1.7×
Simone M. Goldinger · 1×
Citations per year

Countries citing papers authored by Zeynep Eroglu

Since Specialization
Citations

This map shows the geographic impact of Zeynep Eroglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeynep Eroglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeynep Eroglu more than expected).

Fields of papers citing papers by Zeynep Eroglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeynep Eroglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeynep Eroglu. The network helps show where Zeynep Eroglu may publish in the future.

Co-authors

The 25 scholars most cited alongside Zeynep Eroglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zeynep Eroglu Line = papers co-authored together Zeynep Eroglu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
Hit paper breakdown →
20182179
2
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Hit paper breakdown →
2016687
3 2017336
4
Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
Hit paper breakdown →
2016317
5 2018302
6 2018283
7 2015274
8 2015257
9 2016248
10
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Hit paper breakdown →
2021215
11 2017200
12 2021172
13 2017158
14 2019144
15 2019137
16 2023130
17 2021124
18 2017114
19 2022109
20 202096

About Zeynep Eroglu

Zeynep Eroglu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 122 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (54 papers), Melanoma and MAPK Pathways (25 papers), Cutaneous Melanoma Detection and Management (22 papers), Nonmelanoma Skin Cancer Studies (10 papers), Brain Metastases and Treatment (9 papers), Polyomavirus and related diseases (8 papers), Hedgehog Signaling Pathway Studies (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Oncology (5.6k citations), Ophthalmology (341 citations), Molecular Biology (1.2k citations), Cancer Research (239 citations) and Immunology (332 citations). Zeynep Eroglu has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Antoni Ribas, Douglas Buckner Johnson, Alexander Noor Shoushtari, Georgina Venetia Long, Jeffrey Alan Sosman, Ryan Joseph Sullivan, Katy K. Tsai, Alexander Maxwell Menzies, Vernon K. Sondak and Jonathan S. Zager. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact